Stock Events

Stock Events

Outlook Therapeutics (OTLK) Q4 2024 Earnings

27DecConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-1.55

-1.05

-0.54

-0.04

Details

Expected EPS

-0.803333

Actual EPS

-0.88

Surprise EPS

-0.08

Surprise Percent

+9.54%

Description

Outlook Therapeutics (OTLK) has reported earnings of -0.88 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.